Aaron Spivak, Ph.D.


Mr. Spivak joined Great Point Partners in 2021.

Previously, Mr. Spivak worked as a Senior Investment Analyst for JFL Capital Management, a short-biased biotechnology hedge fund. Prior to JFL Capital Management, Mr. Spivak worked as an analyst in health care for Palkon Capital Management, a long/short equity hedge fund.  Mr. Spivak started his career at GlaxoSmithKline as a Scientific Investigator in Computational Biology.

Mr. Spivak holds an MBA from Harvard Business School and a PhD in Computational & Systems Biology from Washington University in St. Louis. Mr. Spivak graduated from Davidson College with a BS in Biology.